지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 발행연도
- 2020.1
- 수록면
- 815 - 829 (15page)
이용수
초록· 키워드
오류제보하기
Purpose While numerous epidemiological studies have indicated that omega-3 polyunsaturated fatty acids have anticancer properties in various cancers, the effects and mechanisms of eicosapentaenoic acid (EPA) in ovarian cancer cell growth are poorly understood. Materials and Methods ES2 ovarian clear cell carcinoma cells and SKOV3 adenocarcinoma cells were treated with palmitic acid or EPA, followed by flow cytometry and cell counting to measure apoptosis and proliferation, respectively. A modified protein lipid overlay assay was used to further verify whether EPA was a ligand of G protein–coupled receptor 30 (GPR30) in ES2 cells. The levels of apoptosis-related genes, phosphorylated AKT, and phosphorylated ERK1/2 were detected to explore the underlying mechanism. Finally, inhibitory effect of EPA on tumor growth via GPR30 was determined in vitro and in vivo. Results EPA suppressed ES2 ovarian clear cell carcinoma cells growth via GPR30, a novel EPA receptor, by inducing apoptosis. As a ligand of GPR30, EPA activated the GPR30-cAMP– protein kinase A signaling pathway. When GPR30 was suppressed by siRNA or its inhibitor G15, the antiproliferative action of EPA was impaired. Furthermore, EPA inhibited tumor growth by blocking the activation of AKT and ERK. In the mouse xenograft model, EPA decreased tumor volume and weight through GPR30 by blocking tumor cell proliferation. Conclusion These results confirm that EPA is a tumor suppressor in human ovarian clear cell carcinoma cells and functions through a novel fatty acid receptor, GPR30, indicating a mechanistic linkage between omega-3 fatty acids and cancers.
목차
등록된 정보가 없습니다.
참고문헌 (0)
참고문헌 신청함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
한국의 의사상에 기반을 둔 일반역량 및 EPA 개발에 관한 연구
대한의사협회 의료정책연구소 연구보고서
2018 .11
-
Low Doses of Nonylphenol Promote Growth of Colon Cancer Cells through Activation of ERK1/2 via G Protein–Coupled Receptor 30
Cancer Research and Treatment
2019 .01
-
Evaluation of Effects of Metformin in Primary Ovarian Cancer Cells
Asian Pacific journal of cancer prevention : APJCP
2015 .01
-
Genistein Inhibits Proliferation of BRCA1 Mutated Breast Cancer Cells: The GPR30-Akt Axis as a Potential Target
대한암예방학회지
2019 .01
-
노출평가에서 젠더 요소 분석 : EPA 노출계수 핸드북 2011을 중심으로
환경독성보건학회 심포지엄 및 학술대회
2017 .10
-
GPR40 Agonism Modulates Inflammatory Reactions in Vascular Endothelial Cells
Diabetes and Metabolism Journal
2022 .05
-
Methyl lucidone induces apoptosis and G2/M phase cell cycle arrest in ovarian cancer cells by targeting PI3K/AKT/NF-κB signaling pathway
한국실험동물학회 학술발표대회 논문집
2019 .01
-
Entrustable Professional Activities (EPAs)
대한외과학회 학술대회 초록집
2023 .05
-
Data Mining for Identification of Molecular Targets in Ovarian Cancer
Asian Pacific journal of cancer prevention : APJCP
2016 .01
-
Anticancer Drugs at Low Concentrations Upregulate the Activity of Natural Killer Cell
대한의생명과학회지
2023 .09
-
Simvastatin Induces Apoptosis and Suppresses Insulin-Like Growth Factor 1 Receptor in Bile Duct Cancer Cells
Gut and Liver
2016 .01
-
Adipose Stromal Cells from Visceral and Subcutaneous Fat Facilitate Migration of Ovarian Cancer Cells via IL-6/JAK2/STAT3 Pathway
Cancer Research and Treatment
2017 .01
-
SIRT7 Exhibits Oncogenic Potential in Human Ovarian Cancer Cells
Asian Pacific journal of cancer prevention : APJCP
2015 .01
-
Fasiglifam (TAK-875), a G Protein-Coupled Receptor 40 (GPR40) Agonist, May Induce Hepatotoxicity through Reactive Oxygen Species Generation in a GPR40-Dependent Manner
Biomolecules & Therapeutics(구 응용약물학회지)
2018 .01
-
How Can We Treat Cancer Disease Not Cancer Cells?
Cancer Research and Treatment
2017 .01
-
DDX53 confers the self-renewal and drug-resistance of ovarian cancer stem-like cells
한국실험동물학회 학술발표대회 논문집
2022 .07
-
Carvacrol improves blood lipid and glucose in rats with type 2 diabetes mellitus by regulating short-chain fatty acids and the GPR41/43 pathway
The Korean Journal of Physiology & Pharmacology
2024 .01
-
유방암 줄기세포 개념 및 제한점
의생명과학
2018 .01
-
Treatment with 2,3,7,8-tetrachlorodibenzo-ρ-dioxin significantly induce ovarian cancer cell growth via CYP1A1 gene expression and have a disruptive effect in ER expressing BG-1 ovarian cancer cells
한국실험동물학회 학술발표대회 논문집
2015 .02
이 논문의 저자 정보
최근 본 자료
댓글(0)
0